Evaluation of soluble CD200 levels in type 2 diabetic foot and nephropathic patients: Association with disease activity
MEDICAL SCIENCE MONITOR, vol.20, pp.1078-1081, 2014 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 20
- Publication Date: 2014
- Doi Number: 10.1265/msm.890517
- Journal Name: MEDICAL SCIENCE MONITOR
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.1078-1081
- Keywords: Biological Markers - analysis, Biological Markers - chemistry, Diabetic Foot - blood, Diabetic Nephropathies - blood, Diabetic Nephropathies - diagnosis, Diabetic Nephropathies - immunology, 25-HYDROXYVITAMIN D, MANAGEMENT, SCD200, OMALIZUMAB, IL-1-BETA, SEVERITY, STRAIL
- Akdeniz University Affiliated: Yes
Abstract
Background: CD200 (OX-2) is a novel immune-effective molecule, existing in a cell membrane-bound form, as well as in a soluble form in serum (s OX-2), which acts to regulate inflammatory and acquired immune responses.